Replimune Group, Inc.
REPL · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $5 |
| Gross Profit | $0 | $0 | $0 | -$5 |
| % Margin | – | – | – | – |
| R&D Expenses | $189 | $175 | $127 | $81 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $36 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $72 | $60 | $51 | $0 |
| Operating Expenses | $262 | $235 | $177 | $117 |
| Operating Income | -$262 | -$235 | -$177 | -$121 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $15 | $19 | $3 | $0 |
| Pre-Tax Income | -$247 | -$215 | -$174 | -$121 |
| Tax Expense | $0 | $0 | $0 | -$3 |
| Net Income | -$247 | -$216 | -$174 | -$118 |
| % Margin | – | – | – | – |
| EPS | -3.07 | -3.24 | -2.99 | -2.26 |
| % Growth | 5.2% | -8.4% | -32.3% | – |
| EPS Diluted | -3.07 | -3.24 | -2.99 | -2.26 |
| Weighted Avg Shares Out | 81 | 67 | 58 | 52 |
| Weighted Avg Shares Out Dil | 81 | 67 | 58 | 52 |
| Supplemental Information | – | – | – | – |
| Interest Income | $21 | $23 | $10 | $0 |
| Interest Expense | $8 | $7 | $4 | $2 |
| Depreciation & Amortization | $6 | $5 | $2 | $5 |
| EBITDA | -$254 | -$228 | -$172 | -$114 |
| % Margin | – | – | – | – |